Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Immune Response”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT06382311
What this trial is testing

Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 991
Early research (Phase 1)Study completedNCT01119521
What this trial is testing

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00097838
What this trial is testing

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

Who this might be right for
HIV Infections
AlphaVax, Inc. 96
Early research (Phase 1)Study completedNCT00370006
What this trial is testing

Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM

Who this might be right for
Cytomegalovirus Infection
University of California, San Francisco 10
Testing effectiveness (Phase 2)Study completedNCT02529904
What this trial is testing

ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults

Who this might be right for
Influenza
University of Oxford 120
Early research (Phase 1)Study completedNCT00961883
What this trial is testing

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 80
Early research (Phase 1)Study completedNCT00709605
What this trial is testing

Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Early research (Phase 1)Study completedNCT00366782
What this trial is testing

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 51
Early research (Phase 1)Study completedNCT01260727
What this trial is testing

Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Testing effectiveness (Phase 2)Study completedNCT05921903
What this trial is testing

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 386
Early research (Phase 1)Study completedNCT00115960
What this trial is testing

Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT03035370
What this trial is testing

Viaskin Pertussis Vaccine Trial

Who this might be right for
Whooping Cough
DBV Technologies 102
Post-approval studies (Phase 4)Looking for participantsNCT05616546
What this trial is testing

Bone Marrow and Peripheral Blood Immune Responses Study

Who this might be right for
Influenza
Emory University 90
Early research (Phase 1)Study completedNCT01571960
What this trial is testing

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT02425241
What this trial is testing

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination

Who this might be right for
HIV
University College, London 41
Not applicableStudy completedNCT03377296
What this trial is testing

Study of Controlled Human Plasmodium Vivax Infection

Who this might be right for
Malaria, Vivax
University of Oxford 2
Testing effectiveness (Phase 2)Study completedNCT00972725
What this trial is testing

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

Who this might be right for
AIDS
GlaxoSmithKline 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation